An idiographic that explains the design of a product called "Designed to Resist Common Methods of Abuse". It has a blue background and white text. The title of the idiographic is written in bold letters at the top. Below the title there is a list of different methods of abuse including "Crushing & Injection" "Chewing" "Aqueous extraction" "Alcohol-induced dose dumping" and "Categories 1 and 3". The idiographic also includes a brief description of the product which states that it is the only ER hydrochloride with approved labeling for abuse deterrence in categories 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 110 111 112 115 116 117 118 122 123 130 129 130.
Category
- 
                                                                        
                                                                                                            Date 2015 Collection 
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![This is a complex data visualization showing the effects of a 10% reduction in [illegible] due to alternate therapy. The Economic impact is -$2705256; there are also bar charts for Utilization analysis and Cost analysis. The logos for Impact (the software company?) and AECB (a pharmaceutical company?) are prominently displayed.](https://oida-resources-images.azureedge.net/public/full/4186e6e1-4a5c-45f7-b069-d47dfcb50f1e.jpeg) 
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                         
                        